PyInvesting

Market research

300039.SHE Shanghai Kaibao Pharmaceutical CO.,Ltd

SHE CNY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
5B
P/E ratio
20.84
Analyst target
7
Dividend yield
1.9%
Beta
0.17

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Shanghai Kaibao Pharmaceutical CO.,Ltd is currently in a long term uptrend where the price is trading 8.7% above its 200 day moving average.

From a valuation standpoint, the stock is 55.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.3.

Shanghai Kaibao Pharmaceutical CO.,Ltd's total revenue sank by 37.5% to $172M since the same quarter in the previous year.

Its net income has dropped by 47.9% to $29M since the same quarter in the previous year.

Finally, its free cash flow grew by 106.8% to $94M since the same quarter in the previous year.

Based on the above factors, Shanghai Kaibao Pharmaceutical CO.,Ltd gets an overall score of 3/5.